Format

Send to

Choose Destination
See comment in PubMed Commons below
Schizophr Bull. 2011 Mar;37(2):291-9. doi: 10.1093/schbul/sbq104. Epub 2010 Sep 22.

Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia.

Author information

1
Department of Psychology, University of Maryland, College Park, MD 20742-4411, USA. jblanchard@psyc.umd.edu

Abstract

Negative symptoms in schizophrenia are related to poor functional outcome, persistent over time, a source of burden for caregivers, and only minimally responsive to currently available medications. A major challenge to developing efficacious interventions concerns the valid and reliable assessment of negative symptoms. In a recent consensus statement on negative symptoms, a central recommendation was the need to develop new assessment approaches that address the limitations of existing instruments. In the current report, we summarize the background and rationale for the Collaboration to Advance Negative Symptom Assessment in Schizophrenia (CANSAS). The CANSAS project is an National Institute of Mental Health-funded multisite study that is constructing a next-generation negative symptom scale, the Clinical Assessment Interview for Negative Symptoms (CAINS). The CAINS is being developed within a data-driven iterative process that seeks to ensure the measure's reliability, validity, and utility for both basic psychopathology and treatment development research.

PMID:
20861151
PMCID:
PMC3044636
DOI:
10.1093/schbul/sbq104
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems Icon for PubMed Central
    Loading ...
    Support Center